1997 Fiscal Year Final Research Report Summary
PREVENTION OF CALCIFICATION IN GLUTARALDEHYDE-TREATED BIOPROSTHESIS
| Project/Area Number |
08457343
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Thoracic surgery
|
|---|
| Research Institution | AKITA UNIVERSITY |
|---|
Principal Investigator |
SEKINE Satoshi AKITA UNIVERSITY,DEPARTMENT OF CARDIOVASCULAR SURGERY ASSOCIATE PROFFESOR, 医学部, 助教授 (80206630)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
JYOTIRMAY Chanda AKITA UNIVERSITY,DEPARTMENT OF CARDIOVASCULAR SURGERY ASSISTANT PROFESSOR, 医学部, 助手 (30292387)
|
|---|
| Project Period (FY) |
1996 – 1997
|
| Keywords | CALCIFICATION / HEPARIN / GULTARALDEHYDE |
|---|
| Research Abstract |
The problem of calcification in porcine aortic (AVs) and pulmonary (PVs) valves and its relationship to gultaraldehyde (GA) is of current interest. Weproposed an anticalcification treatment to develop non-calcifying porcine AVs and PVs.
Porcine AVs and PVs were cross-linked in GA.Partially degraded heparin was coupled to the GA-treated AVs and PVs through intermediate surface-bound substrate containing amino groups. Control AVs and PVs were cross-linked in 0.625% GA but had no heparin coupling. All specimens were implanted subdermally in 3-week old rats for 5 months for calcification studies.
Control AVs (Ca, 233.69+42.61mg/g) and PVs (Ca, 181.48+4.06) were severely calcified. Coupling of partially degraded heparin revealed complete prevention of calcification in GA-treated AVs (Ca, 0.73+0.27mg/g) and PVs (Ca, 1.125+0.22mg/g) implanted snbcutaneously in weanling rats for 5 months.
The proposed anticalcification treatment is effective in preventing calcification of GA-treated AVs and PVs implanted subcutaneously in weanling rats for 5 months.(Ann Thorac Surg 1997 ; 64 : 1063-6)
|
Research Products
(4 results)
